Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
IP Group

IP Group

IP Group principally invests in university derived technologies and has strong interests in 4 main sectors (Biotech, Cleantech, Healthcare and Technology). Their current portfolio includes around 100 companies including 17 listed on AIM.
J&J Innovation

J&J Innovation

J&J Innovation seeks to positively impact human health through innovation. It does this by helping entrepreneurs realize their dreams of creating healthcare solutions through robust exchange of ideas and through providing resources to support company development.
Kurma Partners

Kurma Partners

Kurma Partner principally invests along the entire value chain from early stage to public companies. 40% of their investments activity is in the early stage, including company formation and seed funding.
LifeArc

LifeArc

LifeArc was formed from MRC Technologies in July 2017 and has diverse interests across the medical sector, including as a co-development partner for new technologies.
Lilly

Lilly

Lilly is a global pharmaceutical company with diverse interests including the discovery of novel technologies that complement their existing portfolio of products.
Longwall Ventures

Longwall Ventures

Longwall Venture Partners LLP invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors
Meltwind Advisory LLP

Meltwind Advisory LLP

Meltwind principally invests in early stage life science/healthcare companies and currently has a portfolio of over 40 companies. Meltwind is based in Cambridge UK and run by Dr Jonathan Milner - founder of Abcam plc and active angel investor.
Midven

Midven

Midven is a West Midlands investor that focuses on the early stage, technology and SME markets, capitalising on their expertise in these areas and has interests in companies seeking up to £1m investment in an initial fundraising round.
Momentum Biotech

Momentum Biotech

Momentum Biotech are investors in emerging life sciences companies with a focus on Seed, Series 'A' and turnaround investment.
New Wave Ventures

New Wave Ventures

New Wave Ventures is a privately owned fund seeking the opportunity to invest in companies with significant growth potential. Our target initial investment is £500,000 to £2,000,000
Norgine Ventures

Norgine Ventures

Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. It provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US.
O2h Ventures

O2h Ventures

An engine for seeding a pipeline of early stage life science and technology assets through research collaborations, in-licencing, spin-outs and investment